107 related articles for article (PubMed ID: 18945767)
1. Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.
Ejegod D; Sørensen KD; Mossbrugger I; Quintanilla-Martinez L; Schmidt J; Pedersen FS
J Virol; 2009 Jan; 83(1):336-46. PubMed ID: 18945767
[TBL] [Abstract][Full Text] [Related]
2. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
4. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
5. Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines.
Nielsen AL; Nørby PL; Pedersen FS; Jørgensen P
J Virol; 1996 Sep; 70(9):5893-901. PubMed ID: 8709209
[TBL] [Abstract][Full Text] [Related]
6. Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.
Ethelberg S; Tzschaschel BD; Luz A; Diaz-Cano SJ; Pedersen FS; Schmidt J
J Virol; 1999 Dec; 73(12):10406-15. PubMed ID: 10559359
[TBL] [Abstract][Full Text] [Related]
7. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.
Nieves A; Levy LS; Lenz J
J Virol; 1997 Feb; 71(2):1213-9. PubMed ID: 8995644
[TBL] [Abstract][Full Text] [Related]
8. Observations on lymphomagenesis and lymphoma in AKR mice. A description of prelymphoma changes in the thymus and phenotypic diversity of lymphomas induced by SL3-3 virus.
Hays EF; Bristol G
Thymus; 1992 Jun; 19(4):219-34. PubMed ID: 1385666
[TBL] [Abstract][Full Text] [Related]
9. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
[TBL] [Abstract][Full Text] [Related]
10. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
Ethelberg S; Hallberg B; Lovmand J; Schmidt J; Luz A; Grundström T; Pedersen FS
J Virol; 1997 Feb; 71(2):1196-206. PubMed ID: 8995642
[TBL] [Abstract][Full Text] [Related]
11. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
[TBL] [Abstract][Full Text] [Related]
12. Impairment of alternative splice sites defining a novel gammaretroviral exon within gag modifies the oncogenic properties of Akv murine leukemia virus.
Sørensen AB; Lund AH; Kunder S; Quintanilla-Martinez L; Schmidt J; Wang B; Wabl M; Pedersen FS
Retrovirology; 2007 Jul; 4():46. PubMed ID: 17617899
[TBL] [Abstract][Full Text] [Related]
13. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression.
Hsiang YH; Spencer D; Wang S; Speck NA; Raulet DH
J Immunol; 1993 May; 150(9):3905-16. PubMed ID: 8473739
[TBL] [Abstract][Full Text] [Related]
14. Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3.
Hays EF; Bristol GC; McDougall S; Klotz JL; Kronenberg M
Cancer Res; 1989 Aug; 49(15):4225-30. PubMed ID: 2545338
[TBL] [Abstract][Full Text] [Related]
15. Generation of lymphomagenic mouse type-C viruses from radiation- or chemically-induced non-producer T-cell lymphoma cell lines infected with non-oncogenic ecotropic virus.
Yanagihara K; Seyama T; Kamiya K; Inoh A; Yokoro K
Jpn J Cancer Res; 1985 May; 76(5):331-7. PubMed ID: 2989062
[TBL] [Abstract][Full Text] [Related]
16. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
Yoshimura FK; Wang T
Virology; 2001 Apr; 283(1):121-31. PubMed ID: 11312668
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of thymic lymphomagenesis by the retrovirus SL3-3.
Hays EF; Bristol G; McDougall S
Cancer Res; 1990 Sep; 50(17 Suppl):5631S-5635S. PubMed ID: 2167159
[TBL] [Abstract][Full Text] [Related]
18. Triple basepair changes within and adjacent to the conserved YY1 motif upstream of the U3 enhancer repeats of SL3-3 murine leukemia virus cause a small but significant shortening of latency of T-lymphoma induction.
Ma SL; Lovmand J; Sørensen AB; Luz A; Schmidt J; Pedersen FS
Virology; 2003 Sep; 313(2):638-44. PubMed ID: 12954229
[TBL] [Abstract][Full Text] [Related]
19. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
Mikkers H; Allen J; Berns A
Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
[TBL] [Abstract][Full Text] [Related]
20. An SL3-3 murine leukemia virus enhancer variant more pathogenic than the wild type obtained by assisted molecular evolution in vivo.
Ethelberg S; Sørensen AB; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Dec; 71(12):9796-9. PubMed ID: 9371648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
